An observational study in Cataract, Diabetic Retinopathy and Macular Edema Due to Diabetes Mellitus, sponsored by Uptown Eye Specialists. Status unknown at 1 site in Canada. Per ClinicalTrials.gov, last updated 2020-12-09.
Sponsored by Uptown Eye Specialists · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Cataract with a site in Canada — 3 open to participants now, 3 under way, none of them phase 3. Cataract · Canada.
Among the 33 studies in Cataract with a site in Canada, this one is the 3rd largest by planned enrollment of the 10 observational ones that give a count, is one of 4 that started in 2019, is one of 10 observational ones, and was the 23rd registered.
1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.
Browse Cataract studies →3 of the 33 studies in Cataract with a site in Canada are open now. Recruiting first, the newest first:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Sites in Canada
Ages 65+ · Healthy volunteers
Bochner Eye Institute · Sites in Canada
Ages 50+
Uptown Eye Specialists · Sites in Canada
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 4 started in 2019.
This study's planned enrollment of 170 is above the median of 90 across 477 observational studies indexed under Cataract.
Median enrollment 68 across the 23 interventional studies, 123 across the 10 observational. Of the 22 that completed or were terminated, 6 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 33 have an industry lead sponsor. The 10 most frequent:
Uptown Eye Specialists is the lead sponsor of 11 studies on the registry; 2 are open to participants now.
Uptown Eye Specialists has 6 studies filed under Cataract — fewer than ten, so there is no comparison to draw.
2 of the studies in Cataract with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07404293Bochner Eye InstituteZero CDE Technique for Lens Removal During FLACS | 2027-03-14 |
| NCT07714174Samuel Lunenfeld Research Institute, Mount Sinai HospitalPost-operative Cognitive Decline After Ambulatory Cataract Surgery in the Elderly Population | 2027-11-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 33 studies in Cataract with a site in Canada, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to use optical coherence tomography angiography (OCT-A) to compare retinal vasculature after uncomplicated cataract surgery in patients with and without diabetic retinopathy.
Patients undergoing cataract surgery who provided informed consent were enrolled in the study. There were three comparison groups: control, diabetic retinopathy (DR) and diabetic macular edema (DME) groups. Optical coherence tomography angiography (OCT-A) scans measuring retinal thickness, vessel density, perfusion density, and foveal avascular zone were obtained at baseline and postoperative week one, month one and month three.
Participants selected from Uptown Eye Specialists, an eye care clinic, at two sites in Brampton, Ontario, Canada and Vaughan, Ontario, Canada.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients undergoing uneventful cataract surgery with no retinal vascular disease.
Procedure: Cataract surgery
Patients with non-proliferative diabetic retinopathy with no diabetic macular edema treatment in the 6 months prior to uneventful cataract surgery.
Procedure: Cataract surgery
Patients with diabetic macular edema undergoing active Anti-VEGF treatment (within the last 3 months) undergoing uneventful cataract surgery.
Procedure: Cataract surgery
Patients undergoing uneventful cataract surgery were recruited to this study if they met the inclusion criteria of the three groups. Postoperative retinal vasculature measures, as recorded by the optical coherence tomography angiography imaging technique, were compared to baseline measures.
Change from baseline of retinal vessel density up to 3 months post-cataract surgery.
Optical coherence tomography angiography (OCT-A) scans will be taken at baseline and postoperative week one, month one, and month three. This imaging modality provides measurements for retinal vessel density to be compared between groups and time.
Time frame: Preoperative (Baseline); Postoperative (1 Week, 1 Month, 3 Months)
Change from baseline of retinal perfusion density up to 3 months post-cataract surgery.
Optical coherence tomography angiography (OCT-A) scans will be taken at baseline and postoperative week one, month one, and month three. This imaging modality provides measurements for retinal perfusion density to be compared between groups and time.
Time frame: Preoperative (Baseline); Postoperative (1 Week, 1 Month, 3 Months)
Change from baseline of foveal avascular zone up to 3 months post-cataract surgery.
Optical coherence tomography angiography (OCT-A) scans will be taken at baseline and postoperative week one, month one, and month three. This imaging modality provides measurements for foveal avascular zone (FAZ), particularly FAZ area, perimeter, and circularity index, to be compared between groups and time.
Time frame: Preoperative (Baseline); Postoperative (1 Week, 1 Month, 3 Months)
Change from baseline of retinal thickness up to 3 months post-cataract surgery.
Optical coherence tomography (OCT) scans will be taken at baseline and postoperative week one, month one, and month three. This imaging modality provides measurements of retinal thickness, particularly, central subfield and average macular cube thickness, to be compared between groups and time.
Time frame: Preoperative (Baseline); Postoperative (1 Week, 1 Month, 3 Months)
Development of new cystoid macular edema
New cases of cystoid macular edema (a potential side effect of cataract surgery) are to be recorded to determine if there are preoperative risk factors for development of cystoid macular edema post-cataract surgery.
Time frame: Preoperative (Baseline); Postoperative (1 Week, 1 Month, 3 Months)
Plan to share: No
Started May 2019 (actual). Primary completion is estimated for Jul 2021, 26 months after the start.
Of 169 non-industry observational studies under Cataract, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 30. This study's planned 26 months is above that.
Counting every sponsor, half of 236 studies reached it within 16 months; a quarter within 9 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Uptown Eye Specialists